XML 66 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments and Fair Value - Schedule of Unrealized Gain (Loss) on Investments (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Amortized Cost $ 70,169 $ 242,228    
Unrealized Gains 9 42    
Fair Value 70,178 242,270    
Cash and cash equivalents 252,831 412,618 $ 204,691 $ 355,447
Marketable Securities   65,538    
Cash        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Marketable Securities   0    
Fair Value, Inputs, Level 1        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Amortized Cost 70,169 242,228    
Unrealized Gains 9 42    
Fair Value 70,178 242,270    
Cash and cash equivalents 84,196 190,638    
Marketable Securities   65,538    
Fair Value, Inputs, Level 1 | Money market funds        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents 14,018 13,906    
Marketable Securities   0    
Fair Value, Inputs, Level 1 | U.S. Treasury securities        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Amortized Cost 70,169 242,228    
Unrealized Gains 9 42    
Fair Value 70,178 242,270    
Cash and cash equivalents 70,178 176,732    
Marketable Securities   65,538    
Cash        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents $ 168,635 $ 221,980